{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:25:14Z","timestamp":1759541114899,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.09.070","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:51:00Z","timestamp":1668646260000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness and safety of injectable human papilloma virus vaccine administered as eyedrops"],"prefix":"10.1016","volume":"41","author":[{"given":"Jiyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Do","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Sol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Jung","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munkhdelger","family":"Jamiyansharav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Chul","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihei Sara","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Yul","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.09.070_b0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/imm.12716","article-title":"Mucosal immune tolerance at the ocular surface in health and disease","volume":"150","author":"Galletti","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2022.09.070_b0010","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2022.09.070_b0015","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.4049\/jimmunol.1000680","article-title":"Eye mucosa: an efficient vaccine delivery route for inducing protective immunity","volume":"185","author":"Seo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2022.09.070_b0020","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.vaccine.2014.04.018","article-title":"Inflammatory responses following intramuscular and subcutaneous immunization with aluminum-adjuvanted or non-adjuvanted vaccines","volume":"32","author":"Kashiwagi","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.070_b0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2022.09.070_b0030","first-page":"164","article-title":"Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen","volume":"76","author":"Challacombe","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2022.09.070_b0035","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.09.070_b0040","article-title":"Inactivated eyedrop influenza vaccine adjuvanted with poly(I:C) is safe and effective for inducing protective systemic and mucosal immunity","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.09.070_b0045","doi-asserted-by":"crossref","first-page":"e0157634","DOI":"10.1371\/journal.pone.0157634","article-title":"Eyedrop vaccination induced systemic and mucosal immunity against influenza virus in ferrets","volume":"11","author":"Yoon","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.09.070_b0050","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2022.09.070_b0055","article-title":"Hypermethylation of PRKCZ regulated by E6 inhibits invasion and EMT via Cdc42 in HPV-related head and neck squamous cell carcinoma","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.vaccine.2022.09.070_b0060","doi-asserted-by":"crossref","first-page":"105774","DOI":"10.1016\/j.oraloncology.2022.105774","article-title":"Impact of HPV status on immune responses in head and neck squamous cell carcinoma","volume":"127","author":"Qureshi","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.vaccine.2022.09.070_b0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2022.09.070_b0070","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1158\/1078-0432.CCR-17-1553","article-title":"Circulating cell-free DNA for metastatic cervical cancer detection, genotyping, and monitoring","volume":"23","author":"Kang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2022.09.070_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cells11142170","article-title":"The diagnostic value of circulating cell-free HPV DNA in plasma from cervical cancer patients","volume":"11","author":"Bonlokke","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.vaccine.2022.09.070_b0080","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1158\/1078-0432.CCR-21-3151","article-title":"Cell-free HPV DNA provides an accurate and rapid diagnosis of HPV-associated head and neck cancer","volume":"28","author":"Siravegna","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2022.09.070_b0085","first-page":"759","article-title":"Langerhans cells in the normal conjunctiva and peripheral cornea of selected species","volume":"21","author":"Rodrigues","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.vaccine.2022.09.070_b0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3949\/ccjm.80a.12084","article-title":"Human papillomavirus vaccine: safe, effective, underused","volume":"80","author":"Jin","year":"2013","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.vaccine.2022.09.070_b0095","doi-asserted-by":"crossref","unstructured":"Lee KE. Issues on current HPV vaccination in korea and proposal statement. kjwhn 2019;25:359\u201364. doi: 10.4069\/kjwhn.2019.25.4.359.","DOI":"10.4069\/kjwhn.2019.25.4.359"},{"key":"10.1016\/j.vaccine.2022.09.070_b0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/11591760-000000000-00000","article-title":"Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach","volume":"25","author":"Garcon","year":"2011","journal-title":"BioDrugs"},{"key":"10.1016\/j.vaccine.2022.09.070_b0105","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1128\/IAI.68.10.5509-5516.2000","article-title":"Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen","volume":"68","author":"Childers","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.09.070_b0110","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2022.09.070_b0115","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2022.09.070_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/v9090246","article-title":"The mouse papillomavirus infection model","volume":"9","author":"Hu","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2022.09.070_b0125","unstructured":"Centers for Disease, C. & Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;59:626\u20139."},{"key":"10.1016\/j.vaccine.2022.09.070_b0130","unstructured":"Centers for Disease, C. & Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;59:630\u20132."},{"key":"10.1016\/j.vaccine.2022.09.070_b0135","first-page":"465","article-title":"AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix(R)): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2022.09.070_b0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/bmjebm-2020-111419","article-title":"Was amorphous aluminium hydroxyphosphate sulfate adequately evaluated before authorisation in Europe?","volume":"26","author":"Petersen","year":"2021","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.vaccine.2022.09.070_b0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/eye.2011.312","article-title":"Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia","volume":"26","author":"Di Girolamo","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.vaccine.2022.09.070_b0150","article-title":"Protection from hemolytic uremic syndrome by eyedrop vaccination with modified enterohemorrhagic E. coli outer membrane vesicles","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.09.070_b0155","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/S1470-2045(14)71191-X","article-title":"FDA approves new upgraded Gardasil 9","volume":"16","author":"Kirby","year":"2015","journal-title":"Lancet Oncol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:23:30Z","timestamp":1759404210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22011926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22011926"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of injectable human papilloma virus vaccine administered as eyedrops","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}